Abstract
Preoperative investigation of thyroid nodules is discussed with emphasis on the use of radionuclide scanning, ultrasound examination, and x-ray fluorescence to decrease the need for unnecessary surgical excision. A follow-up program is described involving the use of 131 I imaging techniques and serial thyroglobulin measurements in patients postoperatively for evaluation of response to treatment and detection of recurrence.
Similar content being viewed by others
References
Byar, D.P., Green, S.B., Dor, P., Williams, D., Colon, J., Grilse, H.A., van Mayer, M., Sylvester, R.J., Van Glabbeke, M.: A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Co-operative Group. Eur. J. Cancer15:1033, 1979
Perlmutter, M., Slater, S.L.: Which nodular goitres should be removed? N. Engl. J. Med.255:65, 1956
Andros, G., Harper, P.V., Lathrop, K.A., McCardle, R.J.: Pertechnetate-99m localization in man with applications to thyroid scanning and the study of thyroid physiology. J. Clin. Endocrinol. Metab.25:1067, 1965
Wagner, H.N., Jr.: The scintillation camera with pinhole collimator in thyroid imaging. Radiology101:133, 1971
Wellman, H.N., Anger, R.T., Jr.: Radioiodine dosimetry and the use of radioiodines other than I131 in thyroid diagnosis. Semin. Nucl. Med.1:356, 1971
Goolden, A.W.G., Glass, B.A., Silvester, D.J.: The choice of a radioactive isotope for the investigation of thyroid disorders. Br. J. Radiol.41:20, 1968
Maisey, M.N., Moses, D.C., Hurley, P.J., Wagner, H.N., Jr.: Improved methods for thyroid scanning. J.A.M.A.223:761, 1973
Ryo, U.Y., Arnold, J., Colman, M., Arnold, M., Favus, M., Frohman, L., Schneider, A., Stachura, M., Pinsky, S.: Thyroid scintigram. Sensitivity with Sodium Pertechnetate Tc99m and gamma camera with pinhole collimator. J.A.M.A.235:1235, 1976
Karelitz, J.R., Richards, J.B.: Necessity of oblique views in evaluating the functional status of a thyroid nodule. J. Nucl. Med.15:782, 1975
Frohman, L.A., Schneider, A.B., Favus, M.J., Stachura, M.E., Arnold, J., Arnold, M.: Thyroid carcinoma after head and neck irradiation evaluation of 1476 patients. In Radiation-Associated Thyroid Carcinoma, De Groot, L.J., Frohman, L.A., Kaplan, E.L., Refetoff, S., editors, New York, Grune & Stratton, 1977, p. 5
Alderson, P.O., Sumner, H.W., Siegel, B.A.: The single palpable thyroid nodule. Cancer37:258, 1976
Shunaoko, K., Sokal, J.E.: Differentiation of benign and malignant thyroid nodules by scintiscan. Arch. Intern. Med.144:36, 1964
Psarras, A., Papadopoulos, S.N., Livadas, D., Pharmakiolis, A.D., Koutras, D.A.: The single thyroid nodule. Br. J. Surg.59:545, 1972
Shambaugh, G.E., III, Quinn, J.L., Oyasu, R., Freinkel, N.: Disparate thyroid imaging combined studies with sodium pertechnetate99Tcm and radioactive iodine. J.A.M.A.228:866, 1974
O'Connor, M.K., Cullen, M.J., Malone, J.F.: A kinetic study of [I131] iodide and [99mTc] pertechnetate in thyroid cancer to explain a scan discrepancy: case report. J. Nucl. Med.18:796, 1977
Massin, J.P., Plauchon, C., Perez, R.: Comparison of99mTc-Pertechnetate and I131 in scanning of thyroid nodules. Clin. Nucl. Med.2:324, 1977
Ridgeway, E.C., Weintraub, B.D., Cevallos, J.L., Rock, M.C., Maloot, F.: Suppression of TSH secretion in the patient with a hyperfunctioning thyroid nodule. J. Clin. Invest.52:2783, 1973
Lahey, F.H.: Preoperative diagnosis of carcinoma of the thyroid in surgery of the thyroid. Surg. Clin. North Am.33:781, 1953
Cowan, R.J.: Thyroid imaging with radionuclides. In Continuing Education Lectures. A Review of Nuclear Medicine. Part I, Proceedings of the South-eastern Chapter, Society of Nuclear Medicine, Atlanta, Georgia, 1976, pp. 2.1–2.15
Miskin, M., Rosen, I.B., Walfish, P.G.: B-mode ultrasonography in the assessment of thyroid gland lesions. Ann. Intern. Med.79:505, 1973
Ma, M., Ong, G.B.: Cystic thyroid nodules. Br. J. Surg.62:205, 1975
Thijs, L.G., Wierner, J.D.: Ultrasonic examination of the thyroid gland, possibilities and limitations. Am. J. Med.60:96, 1976
Miller, J.M., Zafar, S.U., Karo, J.J.: The cystic thyroid nodule. Radiology110:257, 1974
Crocker, E.F., McLoughlin, A.F., Kossof, G.: The grey scale echographic appearance of thyroid malignancy. J.C.U.2:305, 1974
Taylor, K.J.W., Carpenter, D.A., Barrett, J.: Grey-scale ultrasonography in the diagnosis of thyroid swelling. J.C.U.2:327, 1974
Chilcote, W.S.: Grey scale ultrasonography of the thyroid. Radiology120:381, 1976
Kaplan, W.D., Holman, B.L., Seleukow, H.A., Davis, M.A., Holmes, R.A., Isitman, A.T., Chandler, H.L.:67Ga-Citrate and the nonfunctioning thyroid nodule. J. Nucl. Med.15:424, 1974
Fukuchi, M., Tachibana, K., Kuwata, K., Nishikawa, A., Hyodo, K., Okamoto, E., Nagai, K.: Thallium-201 imaging in a thyroid carcinoma—appearance of a lymph-node metastasis. J. Nucl. Med.19:195, 1978
Koutras, D.A., Pandos, P.G., Sfontouris, J., Koukoulommati-Spentza, A., Psarras, A., Malamos, B.: Thyroid scanning with Gallium-67 and Cesium-131. J. Nucl. Med.17:268, 1976
Weinstein, M.B., Ashkar, F.S., Caron, C.D.:75Se Selenomethionine as a scanning agent for the differential diagnosis of the cold thyroid nodule. Semin. Nucl. Med.1:390, 1971
Mori, T., Hamamoto, K., Onayama, Y., Torizuka, K.: Tumour imaging after administration of99mTc labelled bleomycin. J. Nucl. Med.16:414, 1975
Scheider, A.B., Favus, M.J., Stachura, M.E., Arnold, J.E., Ryo, U.Y., Pinsky, S., Colman, M., Arnold, M.J., Frohman, L.A.: Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation. Ann. Intern. Med.86:29, 1977
Patton, J.A., Hollifield, J.N., Brill, A.B., Lee, G.S., Patton, D.D.: Differentiation between malignant and benign solitary thyroid nodules by fluorescent scanning. J. Nucl. Med.17:17, 1976
Tadros, T.G., Maisey, M.N., Tang Fui, S.C.N., Turner, P.C.: The iodine concentration in benign and malignant thyroid nodules using x-ray fluorescence. Accepted for publication by B.J. Surg.
Pochin, E.E.: Radioiodine therapy of thyroid cancer. Semin. Nucl. Med.1:503, 1971
Edmonds, C.J., Smith, T., Barnaby, C.F.: Follow-up of thyroid carcinoma by whole body counting. B.J.R.43:868, 1970
Edmonds, C.J., Hayes, S., Kermode, J.C., Thompson, B.D.: Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. B.J.R.50:799, 1977
Stahl, T.J., Shapiro, B.: Use of human thyrotropin radioimmunoassay in the management of patients with thyroid carcinoma. J. Nucl. Med.14:900, 1973
Bekerman, C., Gottschalk, A., Hoffer, P.B.: Optimal time for131I total body imaging to detect metastatic thyroid carcinoma, abstracted. J. Nucl. Med.15:477, 1974
Thomas, S.R., Maxon, H.R., Kereiakes, J.G., Saenger, E.L.: Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well differentiated thyroid cancer. Radiology122:731, 1977
Hershman, J.M., Edwards, C.L.: Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: implications for I131 treatment of thyroid carcinoma. J. Clin. Endocrinol. Metab.34:814, 1972
Krishnamurthy, G.T., Blahd, W.H.: Diagnostic and therapeutic implications of long-term radioisotope scanning in the management of thyroid cancer. J. Nucl. Med.13:924, 1972
Hamburger, J.I.: Diuretic augmentation of131I uptake in inoperable thyroid cancer. N. Engl. J. Med.280:1091, 1969
Rall, J.E., Miller, W.N., Foster, C.G., Peacock, W.C., Rawson, R.W.: The use of thiouracil in the treatment of metastatic carcinoma of the thyroid with radioiodine. J. Clin. Endocrinol. Metab.11:1273, 1951
Preisman, R.A., Halpern, S.: Detection of metastatic thyroid carcinoma after the administration of a therapeutic dose of131I-Iodine. Eur. J. Nucl. Med.3:69, 1978
Henk, J.M., Kirkman, S., Owen, G.M.: Whole body scanning and I131 therapy in the management of thyroid carcinoma. B.J.R.45:369, 1972
Bonte, F.J., McConnell, R.W.: Pulmonary metastases from differentiated thyroid carcinoma demonstrable only by nuclear imaging. Radiology107:585, 1973
Turner, J.E., Weir, G.J., Jr.: Pulmonary metastases from thyroid carcinoma detectable only by131I scan. Treatment and response. J. Nucl. Med.13:852, 1972
Woolfenden, J.M., Waxman, A.D., Wolfstein, R.S., Siemsen, J.K.: Scintigraphic evaluation of liver metastases from thyroid carcinoma. J. Nucl. Med.16:669, 1975
Attie, J.N.: Feasibility of total thyroidectomy in the treatment of thyroid carcinoma. Postoperative radioactive iodine evaluation of 140 cases. Am. J. Surg.138:555, 1979
Gardet, P., Parmentier, C., Gerard-Marchant, R., L'Heritier, C., Caillou, B., Cukersztein, W., Tubiana, M.: Differentiated cancers of the thyroid: course after treatment with special reference to frequency and chronology of the first relapse for 470 treated patients. Ann. Radiol. (Paris)20:831, 1977
Van Herle, A.J., Uller, R.P.: Elevated serum thyroglobulin. A marker for metastases in differentiated thyroid carcinoma. J. Clin. Invest.56:272, 1975
Lo Gerfo, P., Stillman, T., Colacchio, D., Feind, C.: Serum thyroglobulin and recurrent thyroid cancer. Lancet1:881, 1977
Ng Tang Fui, S.C., Hoffenberg, R., Black, E.G., Maisey, M.N.: Serum thyroglobulin concentration and whole-body radioiodine scan in the follow-up of differentiated thyroid cancer after thyroid ablation. Br. Med. J.2:298, 1979
Hoffman, D.P., Surks, M.I., Oppenheimer, J.H., Weitzman, E.D.: Response to thyrotrophic releasing hormone: an objective criteria for the adequacy of thyrotrophic suppression therapy. J. Clin. Endocrinol. Metab.44:892, 1977
Lombery, B.A.: Choosing thyroxine dose after treatment of thyroid cancer. Lancet11:1280, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maisey, M.N. Methods of investigation in the diagnosis and management of thyroid carcinoma. World J. Surg. 5, 49–57 (1981). https://doi.org/10.1007/BF01657834
Issue Date:
DOI: https://doi.org/10.1007/BF01657834